Elicio Therapeutics Inc.
ELTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.39M
Close$
$0.26
91.6% downside
Current Fair Value
91.6% downsideOvervalued by 91.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $53.39 Million |
|---|---|
| Enterprise Value | $43.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.58 |
| Beta | 1.79 |
| Outstanding Shares | 18,211,745 |
Return
| Return on Equity | 2796.45% |
|---|---|
| Return on Assets | -177.11% |
| Return on Invested Capital | -246.73% |
Valuation & Multiples
| P/E Ratio | -1.19 |
|---|---|
| PEG | -21.66 |
| Price to Sales | - |
| Price to Book Ratio | -3.16 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.14 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | -3.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.53
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2152▼ 874.22% |
|---|---|
| Total Calls | 405,200▲ 1051.14% |
| Total Puts | 87,200▼ 72.34% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 14.50%▲ 2.04% |
|---|---|
| Total Invested | $28.22M▲ 70.47% |
| Investors Holding | 53▲ 13.00% |
ESG Score
No data
About Elicio Therapeutics Inc
2,021 employees